Published in Nitric Oxide on June 01, 1999
Effects of nitric oxide synthase inhibition with or without cyclooxygenase-2 inhibition on resting haemodynamics and responses to exendin-4. Br J Pharmacol (2006) 0.84
Protective role of selective nitric oxide synthase inhibitor for treatment of decompensated hemorrhagic shock in normotensive and hypertensive rats. Int J Prev Med (2012) 0.75
Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol (2008) 2.24
The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia (2006) 2.09
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol (2008) 1.94
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
Asthma severity and medical resource utilisation. Eur Respir J (2004) 1.74
Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol (1999) 1.65
Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy (2002) 1.63
Effects of hyperinsulinemia on plasma levels of circulating adhesion molecules. J Clin Endocrinol Metab (2000) 1.56
Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob Agents Chemother (1999) 1.54
bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat Med (1998) 1.50
Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med (2001) 1.50
Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther (1999) 1.50
Ocular blood flow and associated functional deviations in diabetic retinopathy. Diabetologia (1999) 1.49
A randomized, placebo-controlled, double-blind crossover study of the effect of pentoxifylline on ocular fundus pulsations. Am J Ophthalmol (1996) 1.47
Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther (2000) 1.46
Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans. Blood (2000) 1.45
Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers. J Nucl Med (1997) 1.44
Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther (1995) 1.44
Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans. J Clin Endocrinol Metab (1997) 1.42
Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure. Int J Clin Pract (2014) 1.41
Studies on the effect of short-term oral dihydroergotamine and troxerutin in patients with varicose veins. Clin Pharmacol Ther (1994) 1.40
Effects of desmopressin on circulating P-selectin. Br J Haematol (1996) 1.39
Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol (1995) 1.34
Research ethics committees in Europe: trials and tribulations. Intensive Care Med (2009) 1.32
Reproducibility and sensitivity of scanning laser Doppler flowmetry during graded changes in PO2. Br J Ophthalmol (1997) 1.32
Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment Pharmacol Ther (2003) 1.25
Noninvasive investigations of the normal ocular circulation in humans. Invest Ophthalmol Vis Sci (1998) 1.23
Evaluation of the Zeiss retinal vessel analyser. Br J Ophthalmol (2000) 1.23
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J Clin Invest (1997) 1.22
Effects of peribulbar anesthesia on ocular blood flow in patients undergoing cataract surgery. Am J Ophthalmol (1999) 1.21
The role of serine hydroxymethyltransferase in cell proliferation: DNA synthesis from serine following mitogenic stimulation of lymphocytes. Biosci Rep (1981) 1.20
Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin. Am J Respir Crit Care Med (1999) 1.19
Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res (2001) 1.19
Clonidine added to bupivacaine enhances and prolongs analgesia after brachial plexus block via a local mechanism in healthy volunteers. Eur J Anaesthesiol (2004) 1.16
Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med (2000) 1.16
Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob Agents Chemother (1999) 1.15
5-fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res (1997) 1.13
Nitric oxide and ocular blood flow in patients with IDDM. Diabetes (1997) 1.11
Heparin blunts endotoxin-induced coagulation activation. Circulation (2000) 1.09
Ocular hemodynamics during isometric exercise. Microvasc Res (2001) 1.07
Assessment of optic disk blood flow in patients with open-angle glaucoma. Am J Ophthalmol (2000) 1.07
Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans. Am J Physiol (1997) 1.05
Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother (1999) 1.04
Menstrual cycle-associated changes in blood levels of interleukin-6, alpha1 acid glycoprotein, and C-reactive protein. J Lab Clin Med (1997) 1.04
Twelve hour reproducibility of choroidal blood flow parameters in healthy subjects. Br J Ophthalmol (2004) 1.04
The effect of a new specific alpha-amylase inhibitor on post-prandial glucose and insulin excursions in normal subjects and Type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1984) 1.03
Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects. Br J Pharmacol (2010) 1.03
A comparison between laser interferometric measurement of fundus pulsation and pneumotonometric measurement of pulsatile ocular blood flow. 1. Baseline considerations. Eye (Lond) (2000) 1.02
Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. Thromb Haemost (2001) 1.01
Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man. Thromb Haemost (1995) 1.00
Reversal of endothelin-1-induced ocular hemodynamic effects by low-dose nifedipine in humans. Clin Pharmacol Ther (1998) 1.00
The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp Eye Res (1997) 1.00
A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother (2000) 0.99
Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina. Invest Ophthalmol Vis Sci (2000) 0.99
Asymmetrical dimethylarginine is related to renal function, chronic inflammation and macroangiopathy in patients with Type 2 diabetes and albuminuria. Diabet Med (2007) 0.99
Elevated procaspase levels in human melanoma. Melanoma Res (2001) 0.99
Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans. Life Sci (1998) 0.98
Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers. Aliment Pharmacol Ther (2003) 0.97
Effects of antiglaucoma drugs on ocular hemodynamics in healthy volunteers. Clin Pharmacol Ther (1997) 0.96
Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model. J Mol Med (Berl) (2001) 0.95
Sex differences in concentrations of exhaled nitric oxide and plasma nitrate. Life Sci (1996) 0.95
Effects of changes in intraocular pressure on human ocular haemodynamics. Curr Eye Res (1997) 0.95
The effect of hyperoxia and hypercapnia on fundus pulsations in the macular and optic disc region in healthy young men. Exp Eye Res (1995) 0.94
C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol (2006) 0.94
The effect of inhalation of different mixtures of O2 and CO2 on ocular fundus pulsations. Exp Eye Res (1996) 0.93
Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice. Int J Cancer (1999) 0.93
Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects. Invest Ophthalmol Vis Sci (2000) 0.93
Dexamethasone down-regulates the expression of L-selectin on the surface of neutrophils and lymphocytes in humans. Clin Pharmacol Ther (1997) 0.92
Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans. Life Sci (2000) 0.92
Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther (1997) 0.92
Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes. J Intern Med (2011) 0.92
Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine. J Cardiovasc Pharmacol (1988) 0.92
Age dependence of choroidal blood flow. J Am Geriatr Soc (1998) 0.91
Effects of endotoxemia on thrombopoiesis in men. Thromb Haemost (1999) 0.91
Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine. Am J Physiol (1997) 0.91
Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo. Circulation (1987) 0.91
[Accidental fatal formaldehyde poisoning]. Wien Klin Wochenschr (1983) 0.91